REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)

58 filings reported holding RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share as of Q4 2024.
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 7.73M shares of 101M outstanding shares and own 7.63% of the company stock.
Largest 10 shareholders include MILLENNIUM MANAGEMENT LLC (1.8M shares), VANGUARD GROUP INC (1.38M shares), ARMISTICE CAPITAL, LLC (1.36M shares), Schonfeld Strategic Advisors LLC (1.06M shares), Parkman Healthcare Partners LLC (514K shares), GEODE CAPITAL MANAGEMENT, LLC (312K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (202K shares), TANG CAPITAL MANAGEMENT LLC (170K shares), Persistent Asset Partners Ltd (161K shares), and BlackRock, Inc. (115K shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.